Guide price only. Final cost is confirmed after assessment.
uFat Regenerative Therapy is a groundbreaking advancement in regenerative medicine. At London Cartilage Clinic, we utilise this cutting-edge technique, focusing on the gentle processing of adipose tissue to preserve mesenchymal Stem Cell / Medicinal Signaling Cells, enhancing the body's natural healing process. uFat therapy stands out for its ability to maintain the integrity of adipose tissue, offering superior regenerative capabilities compared to traditional methods.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026
uFat focuses on gentle adipose processing to better preserve cellular architecture and stromal vascular niches that support tissue repair.
uFat and mFat are both valuable; selection depends on tissue target, required potency, and treatment objectives.
uFat is minimally invasive and designed to deliver regenerative tissue support with less disruption than more aggressive processing techniques.
At London Cartilage Clinic, uFat is integrated into a full care plan that includes diagnosis, procedural precision, and follow-up to track clinical response.
uFat therapy differs in its focus on preserving the structural integrity and cellular composition of adipose tissue. This results in a product richer in mesenchymal Stem Cell / Medicinal Signaling Cells, offering more potent regenerative properties.
uFat therapy is effective for a variety of conditions, including osteoarthritis, tissue injuries, and in cosmetic applications for tissue regeneration and anti-aging treatments.
Recovery times for uFat therapy are typically minimal, with most patients resuming normal activities within a short period. However, the specific recovery time can vary depending on the individual case.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
ChondroFiller is an injectable collagen scaffold that prompts the patient's own progenitor cells to regenerate cartilage defects; it holds CE Class III approval, and published prospective data document functional improvements of approximately 30 points sustained at three-year follow-up.
An unloader brace applies a corrective force that opens the medial joint space and shifts body weight toward the lateral compartment. Pain relief is not symptom masking but reflects the resulting reduction in mechanical stress on damaged cartilage.
Walking safety after a torn meniscus depends on tear stability, not pain: stable degenerative tears tolerate controlled weight-bearing, whilst unstable fragments risk progressive damage.
